Melatonin may protect the small intestine from oral radiation treatment in rats

April 12, 2017

Oral melatonin can protect the small intestine in rats subjected to radiotherapy of the tongue, according to a study published April 12, 2017 in the open-access journal PLOS ONE by Germaine Escames from Universidad de Granada, Spain, and colleagues.

Gut toxicity -- a debilitating condition involving deep ulcerations -- can limit the doses of radiotherapy given to cancer patients. However, this side effect currently has no effective treatment. Following up on their previous work suggesting that melatonin might protect the gut from radiotherapy, Escames and colleagues irradiated the tongues of rats daily for five days, treated the rats with oral melatonin-gel for 21 days after radiation, and then assessed their small intestines for changes.

The researchers found that melatonin helped protect the small intestine of rats from radiotherapy, likely by protecting mitochondria and so reducing inflammation. Inflammatory mediators increase intestinal cell death, and the researchers found that melatonin reduced intestinal cell death in rats, thus facilitating intestinal recovery. This work suggests that oral treatment with melatonin might help prevent radiotherapy-induced gut toxicity in cancer patients.
In your coverage please use this URL to provide access to the freely available article in PLOS ONE: pone.0174474

Citation: Fernández-Gil B, Moneim AEA, Ortiz F, Shen Y-Q, Soto-Mercado V, Mendivil-Perez M, et al. (2017) Melatonin protects rats from radiotherapy-induced small intestine toxicity. PLoS ONE 12(4): e0174474. doi:10.1371/journal.pone.0174474

Funding: This study was partially supported by grant no. SAF2009-14037 from the Spanish Ministry of Economy and Competitivity (MINECO), GREIB.PT_2010_04 from the CEIBiotic Program of the University of Granada, Spain, and CTS-101 from the Consejería de Innovación, Ciencia y Empresa, Junta de Andalucía, Spain.

Competing Interests: Patent pending: This study has been submitted to the patent's offices at the "University of Granada". Please note that the results of this manuscript have been submitted to patent protection (application number P201130792; title: "Use of melatonin for treating and/or preventing mucositis"; date:17/1/2015). However, this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.


Related Radiotherapy Articles from Brightsurf:

Genomic analysis predicts survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in low-grade gliomas in NRG Oncology clinical trial
A practice-changing study, NRG Oncology clinical trial NRG-RTOG 9802, has demonstrated, for the first time, a survival benefit of adjuvant chemotherapy following radiotherapy over radiotherapy alone in certain subgroups of patients with high-risk, low-grade glioma (WHO classification: LGG, grade II), a type of brain tumor that originates from glial cells.

Outcomes in radiotherapy-treated patients with cancer during COVID-19
The delivery of radiotherapy in 209 patients with cancer during the COVID-19 outbreak in Wuhan, China, is evaluated in this case series.

Shorter radiotherapy treatment for bowel cancer patients during COVID-19
An international panel of cancer experts has recommended a one-week course of radiotherapy and delaying surgery as the best way to treat patients with bowel cancer during the COVID-19 pandemic.

The pros and cons of radiotherapy: Will it work for you?
Women undergoing radiotherapy for many cancers are more likely than men to be cured, but the side effects are more brutal, according to one of Australia's most experienced radiation oncology medical physicists.

How to keep boron inside cells during radiotherapy: a novel approach to cancer treatment
Boron neutron capture therapy (BNCT) is a technique in which p-boronophenylalanine (BPA) is transferred to cancer cells, and the boron in it undergoes nuclear fission reaction upon irradiation of thermal neutrons, releasing high energy particles that kill the cells.

Prolonged breath-holding could help radiotherapy treatment of cardiac arrhythmias
A technique that enables patients suffering from heart conditions to hold their breath safely for over five minutes could have potential as part of a new treatment for cardiac arrhythmias, say researchers at the University of Birmingham.

Zebrafish 'avatars' can help decide who should receive radiotherapy treatment
To date, there is no method for clearly determining whether radiotherapy will be an effective treatment for individual cancer patients.

One dose of radiotherapy as effective as five doses for cancer in the spine
A single dose of radiotherapy is as 'effective' as five doses for end-of-life cancer patients suffering with painful spinal canal compression, finds a large study conducted by UCL.

Personalized and powerful: UK to lead next-generation radiotherapy research
The UK will be transformed into a global hub for radiotherapy research, pioneering the use of the latest techniques such as FLASH radiotherapy and artificial intelligence, with a new £56 million research network announced by Cancer Research UK today.

Oxygen in hyperbaric chamber provides relief after radiotherapy
Hyperbaric oxygen therapy (HBOT) can relieve self-reported symptoms and side-effects of radiotherapy against cancer in the pelvic region, a study shows.

Read More: Radiotherapy News and Radiotherapy Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to